We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This document sets out for the programme specific operating model (PSOM) for quality assurance of the NHS antenatal and newborn (ANNB) screening programmes.
Requirements for the quality assurance of laboratories providing antenatal and newborn screening services by the United Kingdom Accreditation Service (UKAS).
Information for parents about congenital hypothyroidism (CHT) following a baby’s screening test result.
Newborn blood spot (NBS) screening guidance for babies under a year of age with no available screening results.
This document describes the newborn blood spot (NBS) screening pathway.
This document explains the guidelines for laboratories screening newborns for cystic fibrosis (CF) in the UK.
Annual reports on data collected by the NHS Newborn Blood Spot (NBS) Screening Programme.
An overview of the newborn blood spot screening end-to-end pathway.
Statutory guidance to help health professionals provide an inclusive screening programme to all eligible people.
Information for commissioners and screening providers, to help improve access to screening for people with severe mental illness.
Information for parents about glutaric aciduria type 1 (GA1) following a baby’s screening test result.
Information for parents of babies with possible maple syrup urine disease (MSUD) following a baby’s screening test result.
Information for parents about congenital hypothyroidism (CHT) following a baby’s positive screening test result.
Information for parents about isovaleric acidaemia (IVA) following a baby’s screening test result.
Information and advice for parents of babies with suspected medium-chain acyl-CoA dehydrogenase deficiency (MCADD) following a baby’s screening test result.
Recommendations for maternity services to help meet the acceptable threshold for the newborn blood spot avoidable repeat tests key performance indicator.
Executive summary of quality assurance (QA) visit to University Hospital Southampton NHS Foundation Trust's antenatal and newborn screening held on 20 April 2017.
Following this clinical pathway will help immunology services and teams to make sure babies are referred into diagnostic testing in the required timescales.
Guidelines for laboratories screening newborns for congenital hypothyroidism (CHT) in the UK.
Guidance on the referral and management of babies with congenital hypothyroidism (CHT).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).